Ontology highlight
ABSTRACT: Background
Hormone Therapy (HT) reduces the risk of breast cancer recurrence and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non-adherence and non-persistence are high. Research suggests this may be due to the impact of HT side effects. However, little research has explored the individual contribution of side effects to non-adherence and non-persistence behaviours, thereby hindering the implementation of targeted intervention strategies. Our aim is to review the published literature on breast cancer survivors' lived experiences of HT side effects and explore how these may be related to non-adherence and non-persistence behaviour.Methods
Electronic searches were conducted from inception to May 2020, utilising Cochrane CENTRAL, Medline,
SUBMITTER: Peddie N
PROVIDER: S-EPMC8165559 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature